SCHEMBL5051271

SCHEMBL5051271

CCC(C(C(=O)O)C(C)c1cccnc1)P(=O)(O)Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM8 O00222 1/20 0.42
GRM4 Q14833 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
KMT2A Q03164 2/20 0.39
PKM P14618 1/20 0.39
ANPEP P15144 1/20 0.39
ERAP2 Q6P179 1/20 0.39
ERAP1 Q9NZ08 1/20 0.39
TBXAS1 P24557 2/20 0.39
GPR132 Q9UNW8 1/20 0.39
SLC1A2 P43004 1/20 0.39
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KCNN4 O15554 2/20 0.38
KCNA5 P22460 2/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
RAB9A P51151 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5057857 0.77 TBXAS1 (0.43) GRM8GRM4L3MBTL1ANPEPERAP2
SCHEMBL5057863 0.77 GRM8 (0.42) GRM8GRM4L3MBTL1KMT2AANPEP
SCHEMBL5051278 0.76 ANPEP (0.52) L3MBTL1KMT2APKMANPEPERAP2
SCHEMBL5053036 0.76 L3MBTL1 (0.43) GRM8GRM4L3MBTL1ANPEPERAP2
SCHEMBL5060437 0.75 TBXAS1 (0.44) GRM8GRM4L3MBTL1KMT2APKM
SCHEMBL5059824 0.74 CYP2D6 (0.46) ANPEPERAP2HPGD
SCHEMBL5060253 0.73 GRM8 (0.46) GRM8GRM4L3MBTL1ANPEPERAP2
SCHEMBL5051354 0.72 ANPEP (0.42) GRM8GRM4L3MBTL1KMT2APKM
SCHEMBL7606691 0.72 GPR132 (0.47) GRM8GRM4L3MBTL1KMT2AGPR132
SCHEMBL5060377 0.71 L3MBTL1 (0.46) GRM8GRM4L3MBTL1KMT2ATBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080311037-A1 Compounds which bind PSMA and uses thereof NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080311037-A1 Compounds which bind PSMA and uses thereof FOLH1, PSMA1, BPHL GRM8 2890/4885GRM4 3118/4885L3MBTL1 904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.